Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Semaglutide GLP-1 injections are called GLP-1 receptor agonists
Date: February 11, 2026 Source: Cochrane Summary: Three major reviews commissioned by the World Health Organization find that GLP-1 drugs including tirzepatide (sold as Mounjaro and Zepbound), semaglutide (Ozempic and Wegovy), and liraglutide (Victoza and Saxenda) can lead to substantial weight loss in people with obesity
That number aligns with clinical trial data for tirzepatide, which showed weight loss ranging from 15% to 22.5% of body weight depending on dose and study duration
Khavinson VKh, Linkova NS, Polyakova VO, Kheifets OV, Tarnovskaya SI, Kvetnoy IM
Lilly also previously announced price cuts for consumers who directly purchase Zepbound
US$ 24.46
US$ 24.21
US$ 26.11
US$ 26.67
US$ 27.00
US$ 20.93
US$ 24.82
US$ 27.79
US$ 25.75
US$ 22.27
US$ 22.34
US$ 21.07
